Identification of the minimal copper(II)-binding alpha-synuclein sequence.

Area of Science:

• Biochemistry
• Neuroscience
• Environmental Health

Background:

• Parkinson's disease (PD) is linked to environmental factors, including transition metals.
• Alpha-synuclein, a presynaptic protein, is also implicated in PD pathogenesis.
• Understanding metal-protein interactions is crucial for PD research.

Purpose of the Study:

• To identify the minimal copper (II) binding sequence within alpha-synuclein peptides.
• To investigate the role of specific residues and the N-terminus in Cu(II) binding.
• To explore the structural implications of Cu(II) binding to alpha-synuclein.

Main Methods:

• Synthesis and use of tryptophan-containing peptides derived from alpha-synuclein.
• Characterization of Cu(II) binding sites using spectroscopic techniques.
• Analysis of excited-state decay kinetics of tryptophan residues.

Main Results:

• The minimal Cu(II)-binding sequence was identified as MDV(F/W) within the first four residues, anchored by the alpha-amino terminus.
• Lysine residues at positions 6 and 10 were found to be non-essential for Cu(II) binding.
• Two distinct quenching modes were observed in Trp4 excited-state decay kinetics, suggesting multiple Cu(II)-polypeptide structures.

Conclusions:

• The N-terminus and the first four residues of alpha-synuclein are critical for Cu(II) binding.
• Cu(II) binding to alpha-synuclein may lead to distinct structural conformations.
• These findings contribute to understanding the role of metal ions in Parkinson's disease.